Olema Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 2 | -$0.54 | -$0.54 | -$0.54 |
| Q2 2024 | 6 | -$0.63 | -$0.50 | -$0.57 |
| Q3 2024 | 2 | -$0.62 | -$0.62 | -$0.62 |
| Q1 2025 | 5 | -$0.57 | -$0.57 | -$0.57 |
| Q2 2025 | 5 | -$0.61 | -$0.61 | -$0.61 |
| Q3 2025 | 5 | -$0.63 | -$0.63 | -$0.63 |
| Q4 2025 | 5 | -$0.68 | -$0.68 | -$0.68 |
| Q1 2026 | 2 | -$0.73 | -$0.73 | -$0.73 |
| Q2 2026 | 2 | -$0.60 | -$0.60 | -$0.60 |
| Q3 2026 | 2 | -$0.63 | -$0.63 | -$0.63 |
| Q4 2026 | 2 | -$0.69 | -$0.69 | -$0.69 |
Olema Pharmaceuticals, Inc. Earnings Date And Information
Olema Pharmaceuticals, Inc. last posted its earnings results on Tuesday, August 6th, 2024. The company reported $-0.54 earnings per share for the quarter, missing analysts' consensus estimates of $-0.54 by $0. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Olema Pharmaceuticals, Inc. has generated $-2 earnings per share over the last year ($-2.14 diluted earnings per share) and currently has a price-to-earnings ratio of -6.19. Olema Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 8th, 2024 based on prior year's report dates.
Olema Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/06/2024 | Q2 2024 | -$0.54 | -$0.54 | 0 | $0 | $0 |
| 05/08/2024 | Q1 2024 | -$0.53 | -$0.56 | -0.03 | $0 | |
| 03/11/2024 | Q4 2023 | -$0.49 | -$0.49 | 0 | $1.88 M | |
| 11/07/2023 | Q3 2023 | -$0.51 | -$0.48 | 0.03 | $0 | |
| 08/08/2023 | Q2 2023 | -$0.73 | -$0.49 | 0.24 | $0 | |
| 05/09/2023 | Q1 2023 | -$0.66 | -$0.67 | -0.01 | $0 | |
| 03/09/2023 | Q4 2022 | -$0.65 | -$0.63 | 0.02 | $0 | |
| 11/08/2022 | Q3 2022 | -$0.79 | -$0.55 | 0.24 | $0 | |
| 08/09/2022 | Q2 2022 | -$0.65 | -$0.82 | -0.17 | $0 | |
| 05/09/2022 | Q1 2022 | -$0.57 | -$0.57 | 0 | $0 | |
| 02/28/2022 | Q4 2021 | -$0.51 | -$0.54 | -0.03 | $0 | |
| 11/10/2021 | Q3 2021 | -$0.47 | -$0.45 | 0.02 | $0 | |
| 08/10/2021 | Q2 2021 | -$0.39 | -$0.42 | -0.03 | $0 | |
| 05/11/2021 | Q1 2021 | -$0.28 | -$0.39 | -0.11 | $0 | |
| 03/17/2021 | Q4 2020 | -$0.50 | $0 | |||
| 09/29/2020 | Q3 2020 | -$0.21 | $0 | |||
| 06/29/2020 | Q2 2020 | -$0.17 | $0 | |||
| 03/30/2020 | Q1 2020 | -$0.12 | $0 | |||
| 12/30/2019 | Q4 2019 | -$0.07 | $0 |
Olema Pharmaceuticals, Inc. Earnings: Frequently Asked Questions
-
When is Olema Pharmaceuticals, Inc.'s earnings date?
Olema Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 8th, 2024 based off last year's report dates.
-
How can I listen to Olema Pharmaceuticals, Inc.'s earnings conference call?
The conference call for Olema Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
-
How can I read Olema Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for Olema Pharmaceuticals, Inc.'s latest earnings report can be read online.
-
How much profit does Olema Pharmaceuticals, Inc. generate each year?
Olema Pharmaceuticals, Inc. (:OLMA) has a recorded net income of $0. Olema Pharmaceuticals, Inc. has generated $-2.14 earnings per share over the last four quarters.
-
What is Olema Pharmaceuticals, Inc.'s price-to-earnings ratio?
Olema Pharmaceuticals, Inc. (:OLMA) has a price-to-earnings ratio of -6.19 and price/earnings-to-growth ratio is 2.5.
